Joanna M. Roy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanna M. Roy has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Basel Musmar
Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Shreveport, Louisiana, USA
4 shared publications - Michael Reid Gooch
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
4 shared publications - Pascal Jabbour
Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
4 shared publications - Robert H. Rosenwasser
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
4 shared publications - Stavropoula Tjoumakaris
Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
4 shared publications - El-Hajj
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
3 shared publications
Latest Publications
- 11 August 2026
- Published by Wolters Kluwer Health in Neurosurgery
Long-Term Recovery Trajectories After Endovascular Treatment of Carotid-Cavernous Fistulas: A Single-Center Cohort Study
BACKGROUND AND OBJECTIVES: Carotid-cavernous fistulas (CCFs) are uncommon arteriovenous shunts that can present with a wide range of nonspecific ophthalmic and neurological symptoms, often leading to diagnostic delays. While endovascular embolization is the primary treatment modality, data on long-term functional outcomes and the prognostic value of baseline symptom burden remain limited. METHODS: We conducted a retrospective single-center cohort study of consecutive patients with angiographically confirmed CCFs treated with endovascular embolization between 2009 and 2025. Clinical outcomes were assessed at early follow-up (median 1.5 months) and long-term follow-up (>1 year; median 52 months). Logistic regression analyses were used to evaluate the association between symptom burden, angiographic occlusion status, and failure of clinical improvement. RESULTS: A total of 107 patients were included (median age: 64 years, 35% male). Diagnostic delays were common (median duration from symptom onset to treatment: 30 days), frequently due to misdiagnosis as inflammatory, infectious, or vascular orbital conditions. Early follow-up demonstrated complete or partial improvement in 91% of patients, with significant progression from partial to complete improvement at long-term follow-up ( P = .001). Complication and repeat treatment rates were low. Neither symptom duration nor number of presenting symptoms was associated with failure of improvement at early or long-term follow-up ( P ≥ .05). Complete angiographic obliteration at the end of the procedure was associated with improved early outcomes (odds ratio 0.09; 95% CI, 0.02-0.39), while complete occlusion at last radiological follow-up predicted favorable long-term outcomes (odds ratio 0.15; 95% CI, 0.02-0.94). CONCLUSION: Endovascular embolization of CCFs is associated with excellent clinical outcomes and sustained long-term improvement. Symptom burden and diagnostic delays did not predict post-treatment recovery, whereas durable angiographic occlusion was a key determinant of outcome. These findings support intervention even in patients presenting late and emphasize the importance of achieving complete fistula occlusion.
- 11 August 2026
- Published by Wolters Kluwer Health in Neurosurgery
Long-Term Recovery Trajectories After Endovascular Treatment of Carotid-Cavernous Fistulas: A Single-Center Cohort Study
BACKGROUND AND OBJECTIVES: Carotid-cavernous fistulas (CCFs) are uncommon arteriovenous shunts that can present with a wide range of nonspecific ophthalmic and neurological symptoms, often leading to diagnostic delays. While endovascular embolization is the primary treatment modality, data on long-term functional outcomes and the prognostic value of baseline symptom burden remain limited. METHODS: We conducted a retrospective single-center cohort study of consecutive patients with angiographically confirmed CCFs treated with endovascular embolization between 2009 and 2025. Clinical outcomes were assessed at early follow-up (median 1.5 months) and long-term follow-up (>1 year; median 52 months). Logistic regression analyses were used to evaluate the association between symptom burden, angiographic occlusion status, and failure of clinical improvement. RESULTS: A total of 107 patients were included (median age: 64 years, 35% male). Diagnostic delays were common (median duration from symptom onset to treatment: 30 days), frequently due to misdiagnosis as inflammatory, infectious, or vascular orbital conditions. Early follow-up demonstrated complete or partial improvement in 91% of patients, with significant progression from partial to complete improvement at long-term follow-up ( P = .001). Complication and repeat treatment rates were low. Neither symptom duration nor number of presenting symptoms was associated with failure of improvement at early or long-term follow-up ( P ≥ .05). Complete angiographic obliteration at the end of the procedure was associated with improved early outcomes (odds ratio 0.09; 95% CI, 0.02-0.39), while complete occlusion at last radiological follow-up predicted favorable long-term outcomes (odds ratio 0.15; 95% CI, 0.02-0.94). CONCLUSION: Endovascular embolization of CCFs is associated with excellent clinical outcomes and sustained long-term improvement. Symptom burden and diagnostic delays did not predict post-treatment recovery, whereas durable angiographic occlusion was a key determinant of outcome. These findings support intervention even in patients presenting late and emphasize the importance of achieving complete fistula occlusion.
- 21 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Incidence and Predictors of Hemorrhagic Conversion After Mechanical Thrombectomy, Experience from a Large Comprehensive Stroke Center
BACKGROUND AND OBJECTIVES: Hemorrhagic conversion (HC) remains one of the most feared complications after mechanical thrombectomy (MT) for acute ischemic stroke and is associated with poor clinical outcomes. Evidence regarding predictors of HC after MT remains inconsistent. We sought to determine the incidence, predictors, and clinical impact of HC in a large contemporary cohort. METHODS: We conducted a retrospective analysis of a prospectively maintained database including consecutive patients who underwent MT for acute ischemic stroke between January 2016 and December 2024. Baseline clinical, radiographical, and procedural variables were collected. Outcomes were compared between patients with and without HC using 1:1 propensity score matching. Multivariable logistic regression was performed to identify independent predictors of HC. RESULTS: Among 896 patients undergoing MT, 267 (29.8%) experienced HC. After propensity score matching, HC remained associated with worse discharge neurological status (National Institutes of Health Stroke Scale 12.7 vs 9.6; P = .013), longer hospital length of stay (12.3 vs 9.9 days; P = .004), higher rates of decompressive craniectomy (9.4% vs 2.2%; P < .001), and increased likelihood of nonhome discharge (83% vs 71%; P < .001). In-hospital mortality was not significantly different after matching. On multivariable analysis, independent predictors of HC included higher admission National Institutes of Health Stroke Scale score (odds ratio [OR]: 1.04), diabetes mellitus (OR: 2.08), chronic kidney disease (OR: 1.76), and ≥3 thrombectomy passes (OR: 1.75). Increasing age (OR: 0.98), Black race (OR: 0.61), stent-retriever alone thrombectomy (OR: 0.53), and posterior circulation strokes (OR: 0.27) were all significantly associated with lower odds of HC. CONCLUSION: HC occurs in approximately one-third of patients undergoing MT and is independently associated with substantial neurological morbidity and healthcare utilization. Stroke severity, metabolic comorbidities, stroke location, and procedural complexity are key determinants of hemorrhagic risk. These findings support the need for enhanced risk stratification, and heightened postprocedural vigilance in high-risk patients.
- 21 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Incidence and Predictors of Hemorrhagic Conversion After Mechanical Thrombectomy, Experience from a Large Comprehensive Stroke Center
BACKGROUND AND OBJECTIVES: Hemorrhagic conversion (HC) remains one of the most feared complications after mechanical thrombectomy (MT) for acute ischemic stroke and is associated with poor clinical outcomes. Evidence regarding predictors of HC after MT remains inconsistent. We sought to determine the incidence, predictors, and clinical impact of HC in a large contemporary cohort. METHODS: We conducted a retrospective analysis of a prospectively maintained database including consecutive patients who underwent MT for acute ischemic stroke between January 2016 and December 2024. Baseline clinical, radiographical, and procedural variables were collected. Outcomes were compared between patients with and without HC using 1:1 propensity score matching. Multivariable logistic regression was performed to identify independent predictors of HC. RESULTS: Among 896 patients undergoing MT, 267 (29.8%) experienced HC. After propensity score matching, HC remained associated with worse discharge neurological status (National Institutes of Health Stroke Scale 12.7 vs 9.6; P = .013), longer hospital length of stay (12.3 vs 9.9 days; P = .004), higher rates of decompressive craniectomy (9.4% vs 2.2%; P < .001), and increased likelihood of nonhome discharge (83% vs 71%; P < .001). In-hospital mortality was not significantly different after matching. On multivariable analysis, independent predictors of HC included higher admission National Institutes of Health Stroke Scale score (odds ratio [OR]: 1.04), diabetes mellitus (OR: 2.08), chronic kidney disease (OR: 1.76), and ≥3 thrombectomy passes (OR: 1.75). Increasing age (OR: 0.98), Black race (OR: 0.61), stent-retriever alone thrombectomy (OR: 0.53), and posterior circulation strokes (OR: 0.27) were all significantly associated with lower odds of HC. CONCLUSION: HC occurs in approximately one-third of patients undergoing MT and is independently associated with substantial neurological morbidity and healthcare utilization. Stroke severity, metabolic comorbidities, stroke location, and procedural complexity are key determinants of hemorrhagic risk. These findings support the need for enhanced risk stratification, and heightened postprocedural vigilance in high-risk patients.
- 20 May 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 412
The impact of BMI on mechanical thrombectomy outcomes, insights from a comprehensive stroke center
Identifying predictors of outcomes following mechanical thrombectomy (MT) for stroke is crucial for selecting patients most likely to benefit from the treatment as well as guiding prognostication efforts. When it comes to the role of Body Mass Index (BMI) as a prognostic marker in that context, the evidence is conflicting. A retrospective analysis of a prospectively maintained database including patients undergoing MT between the 2016 and 2024 was performed. The main outcomes were functional recovery (discharge modified Rankin Scale (mRS); < 3 vs. ≥3), discharge National Institute of Health Stroke Scale (NIHSS) score, and in-hospital mortality. Multivariable regression and propensity score matching (PSM) were used. A total of 894 patients were included: 16 (1.8%) underweight, 298 (33%) normal weight, 291 (33%) overweight, and 289 (32%) obese (18% class 1, 8.8% class 2, and 4.9% class 3 obesity). On adjusted multivariable regression analyses, none of the BMI categories were associated with discharge mRS (p ≥ 0.05). However, underweight status was an independent positive predictor of both discharge NIHSS score (β = 8.5, 95% CI 3.5–14, p = 0.001), and in-hospital mortality (OR = 6.27, 95% CI 0.95–34.4, p = 0.040). No associations between either discharge NIHSS score or mortality and other BMI categories could be found (p ≥ 0.05). After PSM, no differences in terms of technical difficulty, including number of thrombectomy attempts, length of procedure, and reperfusion success, could be established on the basis of BMI (p ≥ 0.05). While obesity was associated with comparable outcomes compared to normal BMI, underweight status was shown to independently worsen outcomes following MT for stroke. Further studies are needed to establish the nature of this association.
- 20 May 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 412
The impact of BMI on mechanical thrombectomy outcomes, insights from a comprehensive stroke center
Identifying predictors of outcomes following mechanical thrombectomy (MT) for stroke is crucial for selecting patients most likely to benefit from the treatment as well as guiding prognostication efforts. When it comes to the role of Body Mass Index (BMI) as a prognostic marker in that context, the evidence is conflicting. A retrospective analysis of a prospectively maintained database including patients undergoing MT between the 2016 and 2024 was performed. The main outcomes were functional recovery (discharge modified Rankin Scale (mRS); < 3 vs. ≥3), discharge National Institute of Health Stroke Scale (NIHSS) score, and in-hospital mortality. Multivariable regression and propensity score matching (PSM) were used. A total of 894 patients were included: 16 (1.8%) underweight, 298 (33%) normal weight, 291 (33%) overweight, and 289 (32%) obese (18% class 1, 8.8% class 2, and 4.9% class 3 obesity). On adjusted multivariable regression analyses, none of the BMI categories were associated with discharge mRS (p ≥ 0.05). However, underweight status was an independent positive predictor of both discharge NIHSS score (β = 8.5, 95% CI 3.5–14, p = 0.001), and in-hospital mortality (OR = 6.27, 95% CI 0.95–34.4, p = 0.040). No associations between either discharge NIHSS score or mortality and other BMI categories could be found (p ≥ 0.05). After PSM, no differences in terms of technical difficulty, including number of thrombectomy attempts, length of procedure, and reperfusion success, could be established on the basis of BMI (p ≥ 0.05). While obesity was associated with comparable outcomes compared to normal BMI, underweight status was shown to independently worsen outcomes following MT for stroke. Further studies are needed to establish the nature of this association.
- Open Access
- 29 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3090
Comparison of Outcomes Among Neurovascular Patients Managed in Dedicated Neurological Intensive Care Units vs. General Intensive Care Units
Background/Objectives: Patients with neurovascular conditions often require multidisciplinary management to optimize recovery. Our systematic review identifies literature comparing outcomes among neurovascular patients managed at dedicated neurological intensive care units (ICUs) compared to general ICUs. Methods: PubMed was searched to identify articles that reported outcomes among patients managed at dedicated neurological ICUs versus general ICUs. Articles that reported outcomes among patients with neurovascular conditions were included. Articles that reported outcomes among patients managed at stroke units were excluded. The Newcastle Ottawa Scale (NOS) was used to assess for risk of bias across individual studies. Results: After a title and abstract screen followed by a full-text review, seven studies met criteria for inclusion. These studies reported outcomes among patients managed for intracerebral hemorrhage (ICH), acute ischemic stroke (AIS) and aneurysmal subarachnoid hemorrhage (aSAH). Two studies reported lower mortality, improved functional outcome and reduced costs among patients with ICH who were managed at dedicated neurological ICUs. Among patients with aSAH, only less-severe cases experienced better functional outcome after management at dedicated neurological ICUs. Six out of seven studies were considered high quality. Conclusions: Our review highlights the potential benefits of receiving care at dedicated neurological ICUs, as evidenced by lower mortality, improved functional outcome and reduced costs in patients with ICH and low-grade aSAH. However, future research is necessary to clarify whether dedicated neurological ICU care confers significant advantage over general ICUs among patients with AIS and other neurovascular conditions.
- 29 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3090
Open AccessComparison of Outcomes Among Neurovascular Patients Managed in Dedicated Neurological Intensive Care Units vs. General Intensive Care Units
Background/Objectives: Patients with neurovascular conditions often require multidisciplinary management to optimize recovery. Our systematic review identifies literature comparing outcomes among neurovascular patients managed at dedicated neurological intensive care units (ICUs) compared to general ICUs. Methods: PubMed was searched to identify articles that reported outcomes among patients managed at dedicated neurological ICUs versus general ICUs. Articles that reported outcomes among patients with neurovascular conditions were included. Articles that reported outcomes among patients managed at stroke units were excluded. The Newcastle Ottawa Scale (NOS) was used to assess for risk of bias across individual studies. Results: After a title and abstract screen followed by a full-text review, seven studies met criteria for inclusion. These studies reported outcomes among patients managed for intracerebral hemorrhage (ICH), acute ischemic stroke (AIS) and aneurysmal subarachnoid hemorrhage (aSAH). Two studies reported lower mortality, improved functional outcome and reduced costs among patients with ICH who were managed at dedicated neurological ICUs. Among patients with aSAH, only less-severe cases experienced better functional outcome after management at dedicated neurological ICUs. Six out of seven studies were considered high quality. Conclusions: Our review highlights the potential benefits of receiving care at dedicated neurological ICUs, as evidenced by lower mortality, improved functional outcome and reduced costs in patients with ICH and low-grade aSAH. However, future research is necessary to clarify whether dedicated neurological ICU care confers significant advantage over general ICUs among patients with AIS and other neurovascular conditions.